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Abstract
Background: The 2007 WHO algorithm for diagnosis of smear-negative pulmonary tuberculosis (PTB) including
Mycobacterium tuberculosis (MTB) culture was evaluated in a HIV prevalent area of Kenya.
Methods: PTB smear-negative adult suspects were included in a prospective diagnostic study (2009–2011). In addition,
program data (2008–2009) were retrospectively analysed. At the first consultation, clinical examination, chest X-ray, and
sputum culture (Thin-Layer-Agar and Lowenstein-Jensen) were performed. Patients not started on TB treatment were
clinically re-assessed after antibiotic course. The algorithm performance was calculated using culture as reference standard.
Results: 380 patients were included prospectively and 406 analyzed retrospectively. Culture was positive for MTB in 17.5%
(61/348) and 21.8% (72/330) of cases. Sensitivity of the clinical-radiological algorithm was 55.0% and 31.9% in the
prospective study and the program data analysis, respectively. Specificity, positive and negative predictive values were
72.9%, 29.7% and 88.6% in the prospective study and 79.8%, 30.7% and 80.8% in the program data analysis. Performing
culture increased the number of confirmed TB patients started on treatment by 43.3% in the prospective study and by
44.4% in the program data analysis. Median time to treatment of confirmed TB patients was 6 days in the prospective study
and 27 days in the retrospective study. Inter-reader agreement for X-ray interpretation between the study clinician and a
radiologist was low (Kappa coefficient=0.11, 95%CI: 0.09–0.12). In a multivariate logistic analysis, past TB history, number of
symptoms and signs at the clinical exam were independently associated with risk of overtreatment.
Conclusion: The clinical-radiological algorithm is suboptimal to diagnose smear-negative PTB. Culture increases significantly
the proportion of confirmed TB cases started on treatment. Better access to rapid MTB culture and development of new
diagnostic tests is necessary.
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Introduction
Diagnosis of tuberculosis (TB) remains an important challenge
to control TB particularly in resource-limited settings. Sputum
smear-microscopy has a low sensitivity especially in Human
Immunodeficiency Virus (HIV) infected patients (24%–61%) [1–
5]. However, this is often the only test available to confirm
pulmonary TB (PTB) in these settings. Clinical and radiographic
criteria have a limited performance to diagnose TB in HIV
infected patients [6,7]. Sputum Mycobacterium tuberculosis (MTB)
culture is the gold standard for smear-negative TB diagnosis, but
requires a good level of infrastructure and technical expertise.
Moreover, conventional culture methods such as Lowenstein-
Jensen (LJ) are slow and have limited impact on therapeutic
decision. Modern culture methods on liquid media such as
Mycobacteria Growth Indicator Tube (MGIT), are more sensitive
and faster [8–10], but have more risk of contamination compared
to LJ [11,12]. Alternative non-commercial rapid culture methods,
such as Microscopic Observation Drug Susceptibility (MODS) or
Thin Layer Agar (TLA), have recovery rates comparable to other
techniques [13–18], and might be more suitable to resource-
limited settings. Recently, a closed automated polymerase chain
reaction (PCR) test, Xpert MTB/RIF assay, has shown good
detection rates with the potential to be used at district health
facility level [19].
In 2007, WHO revised the smear-negative PTB diagnostic
algorithm in order to improve PTB diagnosis in HIV prevalent
and resource-constraint settings [20]. The revised guideline
recommended performing a chest X-ray before the antibiotic trial
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revised algorithm was implemented at the Homa Bay District
Hospital, a HIV prevalent area in Western Kenya. Me ´decins Sans
Frontie `res (MSF) in collaboration with the supranational reference
laboratory of the Institute of Tropical Medicine Institute in
Antwerp (Belgium) and the Ministry of Health of Kenya set up a
MTB culture laboratory introducing TLA and LJ methods.
Recently, WHO have recommended using Xpert MTB/RIF as
the initial diagnostic test for TB [21]. However, this new
technology is barely available and clinical-radiological algorithms
are largely used to diagnose smear-negative PTB in the peripheral
sites of resource-limited settings.
Few studies have assessed the performance of the 2007 WHO
revised diagnostic algorithm in HIV prevalent settings [22–25].
We conducted a field evaluation of the algorithm in outpatient
smear-negative PTB suspects in Homa Bay to assess the
performance of the clinical-radiological algorithm for the initiation
of TB treatment using culture as reference standard and to
compare the proportion of confirmed TB patients started on TB
treatment using the diagnostic algorithm with and without culture.
Methods
Study design
A prospective diagnostic study was conducted. In addition
program data were retrospectively collected from a period before
the start of the prospective study.
Prospective study
Setting and population. The Homa Bay District Hospital is
the reference health facility for a district of 350,000 people. TB
and HIV care are supported by MSF. Between September 2009
and February 2011 all consecutive smear-negative PTB suspects
attending the hospital TB clinic were eligible to the study if they
were 15 years or more of age, presented with a cough of at least 2
weeks, had 2 negative sputum smears without any positive, and
lived within the hospital TB clinic catchment area for TB
treatment (10 km radius). Patients who had taken fluoroquino-
lones or anti-TB drugs in the last one month were excluded.
Diagnostic algorithm. Three sputum samples collected one
on spot and two early in the morning the following day, were
examined with smear microscopy in all PTB suspects. Smear-
positive patients were started on TB treatment and not included in
the study. Culture was systematically performed for smear-
negative patients. At the 1
st consultation, all smear-negative
patients were clinically assessed by a trained clinical officer, and a
Figure 1. Diagnostic algorithm for smear-negative TB suspects (prospective study).
doi:10.1371/journal.pone.0051336.g001
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suggestive of TB or presenting highly suggestive TB symptoms and
in severe clinical condition were started on TB treatment. Patients
not fulfilling these conditions were given an antibiotic (amoxicillin
1g3 6/day 5 days). HIV testing with pre and post test counselling
was offered to all TB suspects. At the 2
nd consultation, five days
later, patients were re-assessed clinically, sputum smear microsco-
py examination was repeated and a clinical decision to or not to
start TB treatment made. Exceptionally, a second antibiotic was
prescribed for one week followed by a 3
rd clinical consultation. At
anytime, patients with positive culture not already on treatment
were contacted or traced at home to start TB treatment as soon as
possible. Patients who missed study appointments were actively
traced. Patients started on TB treatment received 2 months of
isoniazid, rifampicin, ethambutol and pyrazinamide (HREZ) and
4 months HR according to the Ministry of Health guidelines [26].
Treatment was delivered under self administrative therapy
combined with patient-centred adherence strategies, with good
treatment adherence as previously reported [27]. All tests and
treatment were free of charge.
Study procedures. In order to assess clinical response after
the antibiotic course, the clinician used at each consultation a
score grading the patients’ symptoms severity between 1 (mild) and
4 (life-threatening). Complete resolution was defined as the
resolution of all clinical symptoms with a normal physical
examination; partial resolution as a clinical improvement with
persistence of clinical symptoms/signs; and no resolution as the
absence of improvement or clinical worsening. Severe clinical
condition, irrespectively of TB diagnosis, was defined by one of the
following signs: respiratory rate .30/minute, temperature
.39uC, tachycardia .120/minute, or unable to walk without
help. Malnutrition was defined according to the body mass index
(BMI): BMI ,18.5 and .17: mild; BMI #17 and .16: moderate;
BMI #16: severe.
Chest X-rays were interpreted by the study clinician. A second
reading by an external radiologist blind to the patient’s clinical
data and to the clinician’s interpretation was performed at the end
of the study to measure the inter-reader agreement. A tick sheet
including pictograms was used for reporting X-ray results by both
the clinician and the radiologist (Appendix). Results were defined
as ‘‘Suggestive of TB’’ by the presence of upper lobe infiltrate,
cavitation, hilar adenopathy, pleural effusion or miliary pattern;
‘‘Compatible with TB’’ when any other sign that the clinician
judged was compatible with TB was present and ‘‘Not TB’’ if the
X-ray was normal or if the clinician judged that the signs present
were not suggestive/compatible with TB [20].
Light Emitting Diode-based fluorescence microscopy after
auramine [28] staining was performed. At least 1 AFB/100HPF
was considered as positive. In case of negative results, each of the
two best quality sputum samples was cultured on both TLA and LJ
media. Prior inoculation specimens were decontaminated using
NALC-sodium hydroxide method with 1% final concentration.
Para-nitrobenzoic acid added to TLA during medium preparation
was used to distinguish between MTB and non-TB mycobacte-
rium (NTM). Identification of colonies from LJ was performed by
subculturing on a TLA plate. After inoculation TLA plates were
incubated in a 5% CO2 incubator and LJ in a standard incubator
at 37uC. TLA plates were read twice a week for six weeks using a
standard light microscope and LJ tubes once a week for eight
weeks by trained laboratory technicians. Quality control of
positive cultures was done at the Central Reference Laboratory
in Nairobi and the supranational TB laboratory at the Institute of
Tropical Medicine in Antwerp, Belgium. Growth of at least 1
MTB microcolony defined a positive TLA result and 1MTB
colony a positive LJ result.
A patient was defined as culture positive if at least one of the
four culture results (LJ or TLA) was positive and culture negative if
at least 2 culture results were negative and none was positive.
NTM result was considered as MTB culture negative result.
Patients with culture contaminated results ($3 contaminated
without any positive results) were excluded from this analysis.
Patients with positive culture were considered as confirmed TB
cases.
DetermineH HIV Rapid Test and Uni-GoldH HIV Rapid Test
were used in succession for HIV testing and Facscount machine
for CD4 count.
Retrospective programmatic assessment
Program data accrued between January 2008 and August 2009
were collected retrospectively from patients’ files and clinic
registers. Data included socio-demographic information, treat-
ment decision by the clinician and culture results. Compared to
the prospective study, the program clinical officer did not receive
specific training on chest-ray reading, pictogram tick sheets were
not used for chest-ray interpretation, antibiotic trial was not
standard, there was no grading of the severity of symptoms, and no
standard case definition of clinical response to the antibiotic
course. Microscopy and MTB culture were done in similar
conditions. MTB culture positive patients not on TB treatment
were traced to start treatment. There was no tracing for patients
missing clinic appointments. Chest-rays were not free of charge.
Sample size and statistical analysis
Sample size estimates was based on the comparison of the
proportion of patients appropriately started on TB treatment
(MTB culture confirmed) using the diagnostic algorithm with and
without culture in the same population of PTB suspects. This was
possible since culture results were expected after the therapeutic
decision by the clinician had been made using clinical and
radiological findings. Using a Mc Nemar’s one side test of equality
of paired proportions (nQuery AdvisorH 5.0) with an estimation of
a minimum increase of 5% of patients adequately started on
treatment using the algorithm with culture and 10% proportion of
total discordant pairs, a risk alpha of 0.05 and a risk beta of 0.20, a
minimum of 231 patients were required. The sample size was
increased to 380 patients to stratify the analysis in HIV infected
patients (70%) and take into account dropouts (15%). All
consecutive PTB suspects attending the clinic during the same
duration of time than the one used for the prospective study were
included in the retrospective analysis.
Data were double entered using Epi-Data 3.0 software (The
EpiData Association, Odense Denmark) and analyzed in StataH
10.0 software (College Station, Texas, USA).
The proportion of confirmed TB patients started on TB
treatment using the 2007 WHO algorithm with and without
considering culture results was calculated. The performance
(sensitivity, specificity, predictive values and likelihood ratios) of
the diagnostic algorithm without culture was calculated using
positive culture as reference standard. Receiver operating charac-
teristic (ROC) analyses were performed and the area under the
curve (AUC) calculated. Results were compared between pro-
spective research and routine program conditions. Multivariate
logistic regressions were performed to identify factors associated
with overtreatment (culture negative patients started on TB
treatment) and undertreatment (culture positive patients not
started on TB treatment) when using the diagnostic algorithm
without culture. Inter-agreement of chest X-ray reading was
Smear-Negative TB Diagnosis Algorithm Performance
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according to Landis and Koch classification [29]. Chi-2 test and
Wilcoxon tests were used to compare qualitative and quantitative
and qualitative data between independent populations. Since the
diagnostic algorithms with and without MTB culture were assessed
in the same patients, we used the McNemar test to compare the
proportions of confirmed TB patients started on TB treatment
using the diagnostic algorithm with and without culture. Results
were presented with a 95% confidence interval (95% CI).
Ethics statement. The protocol for both the prospective
study and the retrospective program data analysis was approved
by the Kenya Medical Research Institute Ethical Review
Committee and by the Ethical Review Committee at the ‘‘Comite ´
de Protection des Personnes’’, Saint Germain en Laye, in France’’.
Written informed consent was obtained from all study participants
Table 1. Patients’ characteristics of the smear-negative PTB suspects included in the prospective study.
All patients (N=380) HIV positive (N=247) HIV negative (N=116) p
Age, median years (IQR) 34 (26–48) 34 (28–46) 37.5 (22–60) 0.469
Female, n (%) 239 (62.9) 159 (64.4) 71 (61.2) 0.559
History of TB, n (%) 92 (24.2) 70 (28.3) 21 (18.1) 0.036
Antibiotic in the past 2 weeks, n (%) 92 (24.2) 59 (23.9) 29 (25.0) 0.611
Amoxicillin 42 (45.6)
Erythromycin 20 (21.7)
Cotrimoxazole 21 (22.8)
Other 9 (59.8)
BMI, median
a, (IQR) 19.7 (18.3–21.5) 19.3 (17.9–20.9) 20.5 (19.0–22.5) ,0.001
Malnourished, n
b (%) 107 (28.2) 86 (34.8) 20 (17.2) ,0.001
Mild malnutrition 64 (59.8) 49 (57.0) 15 (75.0)
Moderate malnutrition 20 (18.7) 17 (19.8) 3 (15.0)
Severe malnutrition 23 (21.5) 20 (23.3) 2 (10.0)
Severe clinical condition, n (%) 27 (7.1) 23 (9.3) 3 (2.6) 0.021
No. of symptoms, median (IQR) 7 (6–8) 7 (6–8) 6 (5–8) 0.085
No. signs at physical exam, median (IQR) 3 (2–4) 3 (3–4) 2 (2–3) ,0.001
Symptoms, n (%)
Fever 331 (87.1) 220 (89.1) 97 (83.6) 0.146
Weight loss 309 (81.3) 213 (86.2) 82 (70.7) ,0.001
Night sweats 299 (78.7) 203 (82.2) 85 (73.3) 0.050
Loss of appetite 245 (64.5) 175 (70.9) 61 (52.6) ,0.001
Haemoptysis 64 (16.8) 41 (16.6) 19 (16.4) 0.958
Clinical examination, n (%)
Adenopathies 238 (62.6) 195 (79.0) 35 (30.2) ,0.001
Temperature $37.5uC 42 (11.1) 35 (14.2) 5 (4.3) 0.005
Ascitis 5 (1.3) 2 (0.8) 2 (1.7) 0.463
X-ray findings, n (%)
Infiltration 284 (74.7) 191 (77.3) 81 (69.8) 0.124
Hilar adenopathy 196 (51.6) 141 (57.1) 49 (42.2) 0.008
Consolidation 87 (22.9) 67 (27.1) 17 (14.7) 0.009
Cavities 29 (7.6) 20 (8.1) 8 (6.9) 0.689
Pleural effusion 24 (6.3) 18 (7.3) 5 (4.3) 0.278
Miliary pattern 5 (1.3) 4 (1.6) 0 (0.0) 0.168
Apical fibrocystic 2 (0.5) 2 (0.8) 0 (0.0) 0.331
a. BMI: body mass index.
b. Malnourished: BMI,18.5.
doi:10.1371/journal.pone.0051336.t001
Table 2. Culture results of smear-negative PTB suspects,
prospective study.
LJ
TLA Positive Negative NTM Contaminated Total
a
Positive 34 16 0 1 51
Negative 10 256 6 17 289
NTM 0 4 1 0 5
Contaminated 0 14 0 5 19
Total 44 292 7 23 364
a. In 2 patients LJ was negative and TLA was not performed.
doi:10.1371/journal.pone.0051336.t002
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before enrolment in the prospective study. The written informed
consent was approved by the Ethics Committees. No consent was
sought for patients included in the retrospective program data
analysis.
Results
Prospective study
Patient’s characteristics. During the prospective study
period, 583 smear-negative PTB suspects were consecutively
screened, 380 (65%) fulfilled the inclusion/exclusion criteria and
were included in the study. Patients’ characteristics, clinical and
chest X-ray findings are presented in table 1. Overall, 68.0% of
Figure 2. Diagnostic and treatment pathway for smear-negative TB suspects (prospective study, N=380).
doi:10.1371/journal.pone.0051336.g002
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Of 238 patients with a WHO staging available, 74.4% were in
stage 3 or 4. The median CD4 count (N=225 patients) was 274
cells/ml (IQR: 145–501) and 83 (35.4%) had less than 200 cells/ml.
HIV positive patients were more often malnourished or in severe
clinical condition, and had more pathological signs at the physical
examination than HIV negative patients.
Thirty two patients did not have final culture result because
cultures were not performed (n=14) or were contaminated
(n=18). Out of the remaining 348 patients, 61 (17.5%) were
positive, 276 (79.3%) negative and 11 (3.2%) had NTM results
(Table 2). Out of 233 HIV infected TB suspects, 48 (20.6%) were
culture positive. The median delay from inoculation to a positive
result was 15 days (IQR: 11–21) with TLA and 23 days (IQR:
17.5–31.5) with LJ.
Diagnostic and treatment pathway. Figure 2 presents the
diagnostic and therapeutic pathway of the prospective study. In
total, 150 (39.5%) PTB suspects were started on TB treatment. Of
the 139 PTB suspects with a final culture result started on TB
treatment, 60 (43.2%) were confirmed TB cases.
The reasons and median time to start TB treatment among
culture positive smear-negative PTB patients are shown in Table 3.
The median time to start confirmed TB patients on treatment was
6 days (IQR: 0–27).
The proportion of confirmed TB cases started on treatment
increased from 55.0% using the clinical algorithm without culture
to 98.3% using the algorithm with culture (p,0.001). Including
culture in the algorithm increased the proportion of confirmed TB
cases started on treatment by 43.3% (95%CI: 29.1–57.5). In HIV
positive patients including culture increased the proportion of
treated cases by 38.3% (95%CI: 22.3–54.3).
X-ray interpretation and antibiotic course. The study
clinician interpreted 59 (15.5%) X-rays as ‘‘suggestive of TB’’, 196
(51.6%) as ‘‘Compatible with TB’’, and 125 (32.9%) as ‘‘Not TB’’.
Patients with an X-ray interpreted as ‘‘Suggestive of TB’’ were
more likely to be MTB culture confirmed (OR: 3.4, 95%CI: 1.8–
6.4, p,0.001) than the ones with X-ray interpreted as ‘‘Compat-
ible with TB’’ or ‘‘Not TB’’. Seven percent of the patients with a
chest X-ray interpreted as ‘‘Not TB’’ were culture positive. The
inter-reader agreement for X-ray interpretation between the
clinician and radiologist was low (Kappa coefficient=0.11,
95%CI: 0.09–0.12). X-rays were interpreted as ‘‘Not TB’’ in
73% of the cases by the radiologist and in 33% of the cases by the
clinician. X-ray interpretation as ‘‘suggestive of TB’’ by the
radiologist had a higher specificity compared to the same
interpretation by the study clinician (98.5% versus 87.0%,
p,0.001).
Of the 313 PTB suspects who received an antibiotic, 85%, had
a partial response. Patients with no response to antibiotic were
more likely to be culture confirmed (OR: 3.8, 95%CI: 1.3–10.8,
p=0.014) than patients with a complete or partial response.
However, 9% of the culture confirmed PTB patients who received
an antibiotic had a complete response.
Retrospective analysis
A total of 406 smear negative PTB suspect patients were
included in the retrospective analysis: 213 (52.5%) females, median
age 32 years (IQR: 25–45). Of the 98 with an HIV test result
available, 71 (72.5%) were positive. A chest X-ray was performed
in 94 (23.2%) of the patients. Out of the 330 patients with a final
culture result, 72 (21.8%) were positive, 257 (77.9%) negative, and
1 (0.3%) had an NTM result. A total of 125/406 (30.8%) patients
were started on treatment and 55 (44%) had a confirmed TB.
The reasons and median time to start TB treatment among
culture positive smear-negative PTB patients are shown in Table 3.
The median time to start confirmed TB patients on treatment was
27 days (IQR: 3–35).
The proportion of confirmed TB cases started on treatment
increased from 31.9% using the clinical algorithm without culture
to 76.4% using the algorithm with culture (p,0.001). Including
culture in the algorithm increased the proportion of confirmed TB
cases started on treatment by 44.4% (95%CI: 31.6–57.3). The
proportion of culture confirmed patients not started on treatment
was 23.6% in program conditions (retrospective analysis) versus
1.7% in the prospective study, p,0.001.
Algorithm performance. The performances of the clinical-
radiological diagnostic algorithms in the prospective study and the
retrospective analysis are presented in Table 4. The sensitivity was
significantly lower in program conditions, 31.9% compared to
55.0% in the prospective analysis (p=0.008). The positive
Table 3. Reasons to start treatment among smear-negative culture confirmed PTB cases in the prospective study and in the
retrospective analysis of program data.
Prospective study (N=60)
a Retrospective program data (N=72)
N( % )
Median time to treat
(days) N (%)
Median time to treat
(days)
Started on TB treatment due to clinical signs and/or X-ray: 33 (55.0) 0 23 (31.9) 1
Chest X-ray suggestive 19 (31.7) 0
Severe clinical condition 3 (5.0) 0
Repeated smear positive 2 (3.3) 6
No response to antibiotic 9 (15.0) 6
Started on TB treatment due to culture result: 26 (43.3) 31 32 (44.4) 34.5
Culture TLA positive 17 (28.3) 22 20 (27.7) 30.5
Culture LJ positive 9 (15.0) 39 12 (16.7) 50
Not started on TB treatment 1 (1.7) - 17
b (23.6) -
a. In one patient, the reason could not be discerned (TLA result available the day of the third consultation).
b. 4 had died by the time they were traced, 2 did not come to the clinic to start treatment, 1 refused treatment, 3 were not found during the tracing and for 7 there was
no information about the tracing.
doi:10.1371/journal.pone.0051336.t003
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tively. The negative predictive value was significantly lower in
program conditions (p=0.02). The positive and negative likeli-
hood ratio was 1.6 (95%CI: 1.1–2.4) and 0.9 (95%CI: 0.7–1.0) in
program conditions and 2.0 (95%CI: 1.5–2.7) and 0.6 (95%CI:
0.5–0.8) in the prospective analysis. The AUC for this algorithm
was 0.59 (95%CI: 0.53–0.64) in the prospective study and 0.56
(95%CI: 0.50–0.61) in the retrospective analysis (Figure 3). Using
data from the prospective study, past TB history, number of
symptoms and signs at the clinical exam were independently
associated with risk of overtreatment (Table 5). No factor was
found associated with undertreatment.
Discussion
In this study, the proportion of smear-negative confirmed PTB
patients started on treatment using the 2007 WHO clinical-
radiological algorithm without culture was low: 55% in the
optimised prospective study and 32% in the retrospective analysis
of program data. The clinical-radiological algorithm had poor
discrimination capacity as shown by the low AUC in the ROC
analyses. In Homa Bay, the clinical-radiological algorithm led to a
high proportion of TB cases missed and a high proportion of
patients overtreated. Our study is in line with most of the studies
carried out in similar settings [6,22,25,30] which have shown low
algorithm sensitivity ranging from 23% to 59%. However,
sensitivities of 80–95% have also been reported [23,24].
Less than one third of patients treated for TB were confirmed
with TB in research and routine conditions. The use of rapid
culture did not reduce the risk of overtreatment since majority of
patients were started on treatment before the culture results.
Indeed, the time to positive results for rapid culture (15 days)
might be still too long to have an impact on the risk of
overtreatment. Other studies [6,22,24,25] have shown similar
low positive predictive values (22%–52%). Only one study has
shown a much higher positive predictive value of 90% [23]. As
empiric treatment in patients with no response to antibiotic trial
and negative investigations is part of the WHO algorithm,
overtreatment is likely. In addition, the fear of missing TB,
especially in HIV infected patients along with the difficulty to
diagnose TB using only clinical-radiological signs may contribute
to overtreatment. Patients having a history of TB and poly-
symptomatic patients were at higher risk of been wrongly started
Figure 3. Clinical-radiological algorithm ROC curves. ROC curve for the clinical-radiological smear-negative diagnostic algorithm without
culture in the prospective study (A) and in the retrospective analysis of program data (B).
doi:10.1371/journal.pone.0051336.g003
Table 4. Performance of the 2007 WHO diagnostic algorithm for smear-negative PTB without culture in the prospective study and
the retrospective analysis of program data (reference: positive culture).
Culture
positive
Culture
negative
Sensitivity, %
(95% CI) Specificity, %
Positive predictive
value, %
Negative predictive
value, %
Prospective study (N=347)
a 55.0 (41.6–67.9) 72.8 (67.3–77.9) 29.7 (21.4–39.1) 88.6 (83.8–92.3)
TB start 33 78
Not start 27 209
Retrospective program data
(N=330)
31.9 (21.4–44.0) 79.8 (74.4–84.6) 30.7 (20.5–42.4) 80.8 (75.4–85.4)
TB start 23 52
Not start 49 206
a. One patient excluded since reason to start TB treatment could not be discerned.
doi:10.1371/journal.pone.0051336.t004
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not predictors of TB [6,31,32].
When MTB culture was included in the algorithm, the number
of patients correctly started on TB treatment increased by 43–44%
in the prospective study and the retrospective analysis. During the
prospective study all culture confirmed TB cases but one were
started on TB treatment, while in routine conditions almost one
forth of the cases were not started on treatment despite having a
positive culture result. This was probably the result of a less
effective tracing in program conditions. In addition, the delay to
start treatment among confirmed TB cases remained acceptable (6
days) in the prospective study while it was very long in routine
conditions (27days) most likely due to the same reason. Similar
findings have been reported in other routine settings [6,22,33]: in
Cambodia 29% of the patients were not started on treatment
despite the culture results and in Soudan enrolment into the
culture programme was suspended due to the number of lost to
follow-up cases. Implementing effective tracing is therefore
essential when introducing MTB culture in the diagnostic
algorithm.
One third of the culture positive TB cases were diagnosed
through chest X-ray at the first consultation. Other studies have
shown that performing the chest X-ray before the antibiotic course
can reduce considerably the time to treatment and as a result
potentially improve the survival of smear-negative HIV infected
patients with advance disease [1,5,32,34,35]. Efforts should be
done in order to have chest X-rays available and free-of-charge in
the peripheral areas of resource limited-settings. Nevertheless, the
performance of the chest X-ray to diagnose TB varies depending
on the reader. In this study the field clinician interpretation was
very different compared to the radiologist one. As described in
other sites [22,34,35], the study clinician interpreted X-rays as
pathological more often than the radiologist leading to a lower
specificity to diagnose TB and a low chest X-ray reading
agreement.
The diagnostic value of the response to antibiotic course is
questionable [34] and its accuracy has shown diverse degrees of
limitation [2,6,31,36,37]. Although complete absence of response
to antibiotic was associated with TB in our study, this finding was
not very helpful for decision-making since majority of the TB
patients had a partial response to antibiotics.
Culture techniques used in Homa Bay laboratory reached
similar or higher detection rates to those found in other settings
[13–15]. A considerable number of patients were positive with
only one of the two techniques and the implementation of both
would be advisable to help in the diagnosis of pulmonary smear-
negative TB.
There were some limitations to this study. The absence of an
independent reference standard prevented comparing the perfor-
mance of the algorithm without culture to the performance of the
algorithm with culture. Although MTB culture is the only
reference standard for PTB diagnosis, it remains an imperfect
gold standard in smear-negative suspects, especially in HIV
infected patients who are likely to have poor quality sputum
specimen.
This study provides evidence of the limitations of the 2007
WHO algorithm when used without culture to diagnose smear-
negative PTB with almost half of confirmed TB cases missed. The
use of rapid culture is justified in HIV prevalent and resource-
constraint settings as recommended by WHO [38]. Nevertheless,
introducing and maintaining good culture facilities in safe
conditions is a challenge for resource-limited countries [11,12].
Feasibility and cost-effectiveness studies are lacking. The new
automated PCR methods such as the Xpert MTB/RIF assay,
recently endorsed by WHO for diagnosis of TB in HIV infected
TB suspects is challenging the role of culture for TB diagnosis in
resource-limited countries [19,38]. However, impact and feasibil-
ity studies of diagnostic algorithms using the new PCR assays are
also required.
In conclusion, the clinical-radiological diagnostic algorithm is
largely suboptimal to diagnose smear-negative PTB. Culture
increases significantly the proportion of confirmed TB cases
started on treatment. Better access to rapid MTB culture and
development of new diagnostic tests is necessary.
Supporting Information
Figure S1 Form used for X-ray interpretation in the
prospective study.
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